SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-24-000324
Filing Date
2024-03-28
Accepted
2024-03-27 18:42:27
Documents
18
Period of Report
2024-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20240326_8k.htm   iXBRL 8-K 31250
2 EXHIBIT 10.1 ex_645636.htm EX-10.1 127026
3 EXHIBIT 99.1 ex_645637.htm EX-99.1 7482
8 ex_645637img001.jpg GRAPHIC 3123
9 igcpharma20240326_8kimg001.jpg GRAPHIC 2039
  Complete submission text file 0001185185-24-000324.txt   339071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA igc-20240322.xsd EX-101.SCH 3206
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20240322_def.xml EX-101.DEF 10590
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240322_lab.xml EX-101.LAB 19959
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240322_pre.xml EX-101.PRE 10950
21 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20240326_8k_htm.xml XML 2723
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 24792556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)